{"record_key":"predxbio-inc","identifier":"predxbio-inc","external_key":"5D7257","title":"PredxBio, Inc.","summary":null,"url":"https://inventions.pitt.edu/startups/predxbio-inc","json_url":"https://inventions.pitt.edu/startups/predxbio-inc.json","object_key":"startups","description":"PredxBio helps drug developers understand how cells interact within tissue and how those patterns relate to treatment response. Its SpaceIQ platform combines spatial biology with explainable AI to turn complex tissue data into insights for target selection, biomarker development, patient stratification and clinical trial design. [1]: https://predxbio.com/\nBuilt on University of Pittsburgh research, the company was cofounded by S. Chakra Chennubhotla, D. Lansing Taylor, Jeffrey L. Fine and Michael J. Becich. Its work brings computational pathology and tumor biology together to help pharmaceutical teams make more informed development decisions, from early discovery through clinical programs. [2]: https://predxbio.com/team/ [1]: https://predxbio.com/","attributes":[{"key":"website","label":"Website","values":["https://predxbio.com/"]},{"key":"sector","label":"Sector","values":["Research Tools"]},{"key":"therapeutic_areas","label":"Therapeutic Areas","values":["Immunology"]},{"key":"funding_stage","label":"Funding Stage","values":["Series A+"]},{"key":"founders","label":"Founders","values":["S. Chakra Chennubhotla","D. Lansing Taylor","Jeffrey L. Fine","Michael J. Becich"]}],"related":[]}